Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins

OBJECTIVE: To describe the response to rituximab in patients with treatment-resistant chronic inflammatory demyelinating polyneuropathy (CIDP) with antibodies against paranodal proteins and correlate the response with autoantibody titers. METHODS: Patients with CIDP and IgG4 anti–contactin-1 (CNTN1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Querol, Luis, Rojas-García, Ricard, Diaz-Manera, Jordi, Barcena, Joseba, Pardo, Julio, Ortega-Moreno, Angel, Sedano, Maria Jose, Seró-Ballesteros, Laia, Carvajal, Alejandra, Ortiz, Nicolau, Gallardo, Eduard, Illa, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561230/
https://www.ncbi.nlm.nih.gov/pubmed/26401517
http://dx.doi.org/10.1212/NXI.0000000000000149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561230/
https://www.ncbi.nlm.nih.gov/pubmed/26401517
http://dx.doi.org/10.1212/NXI.0000000000000149

Ejemplares similares